The PBM fee rule reaches employer plans in July 2027 unless a court or the Labor Department stops it first
The Labor Department finalized the rule on October 29th, 2026, and the PBM lobby says it oversteps, though no lawsuit is reported yet. Where the rule stands on March 31st, 2027 turns on a court order or a delay notice.
- If nothing changes
- If nothing unusual happens, the rule is still on schedule on March 31st, 2027. No court has stayed it and no delay notice has been published.
- What it depends on
- Whether a federal court blocks the rule before July 1st, 2027, and whether the Labor Department keeps the date.
The rule takes effect. It still applies only to plan years that start on or after July 1st, 2027.
Has a federal court turned down a PBM request to block the rule?
Has a federal court blocked the rule nationwide?
Has the Labor Department posted a grace period for PBM disclosures?
Has a major news outlet reported a PBM fraud charge or pricing scandal tied to the case?
Is there still no delay notice in the Federal Register and no court stay?
Plan years that start on this day are the first under the rule.
Calendar-year plans first fall under the rule.
- Rule finalizedOctober 29th, 2026
- Rule takes effectJanuary 4th, 2027
- Last day a stay or delay notice countsMarch 31st, 2027
- First plan years under the ruleJuly 1st, 2027
The Labor Department finalized the rule on October 29th, 2026. It makes pharmacy benefit managers (PBMs) disclose their pay to large employers' self-insured health plans. PBMs run the drug benefits in those plans.2
PBMs must show employers the rebates they get from drug makers. They must also show the spread they keep when a plan pays more than the pharmacy receives. Employers can audit these disclosures once a year.3
The Department says the rule could cut drug costs for plans and workers by as much as $22 billion over 10 years. Self-insured employer plans cover about 90 million Americans. The Department says it issued the rule under the federal law on employer benefit plans, to carry out reforms Congress passed in 2026.2
The Pharmaceutical Care Management Association (PCMA) is the PBM industry's lobby. Its president and chief executive, David Marin, said the Department may have exceeded Congress's intent and its own authority. He said PCMA "will evaluate available pathways" against what he called regulatory overreach.11
No page we gathered reports a lawsuit against the rule itself as of November 15th, 2026. Axios, a news site, wrote on October 30th that the rule could still be challenged in court.14
STAT, a health news site, reported that PBMs and lobbyists had warned they may take legal action over the proposal. Federal officials estimate the rule covers more than 70 PBMs and 130,000 employers, STAT reported.15
Two bodies can take the rule off schedule: a court and the Department. The Administrative Procedure Act is the law that governs federal rules. Under it, a court reviewing a rule may postpone its effective date, as far as needed to prevent irreparable injury. The agency may postpone the date itself, pending court review, when it finds that justice requires it.8
A court may issue a preliminary injunction only after notice to the other side. A temporary restraining order can come without notice. It lasts at most 14 days unless the court extends it.10
At the end of a case, the same law tells a court to set aside a rule that goes beyond the agency's legal authority. That is the fault Marin says the rule may have.9
PCMA has gone to court before. In June 2026 it sued Tennessee and Illinois over their state PBM laws, in the same week.7
It has also sued over a federal disclosure rule. In August 2021 it challenged a rule that made PBMs post their rebate amounts in public. It withdrew the suit after talks with the Biden administration.12
The rule takes effect on January 4th, 2027. It applies to plan years that begin on or after July 1st, 2027.1
The rule still on schedule
- A lawsuit fails and the rule stays on time
- Guidance and early audits settle the rule in
- Leaked pricing data moves opinion, not courts
The rule in doubt but standing
- Court and agency delays slow the rule
- PBMs and employers fight over the rule
- A PBM settlement bends the rule
- A split inside the administration on enforcement
- Quiet deals soften the rule
Delayed by the Department or a court
- A rulemaking challenge meets a fraud case
- PBM lawsuits on several fronts at once
- A court blocks the rule before July
- Short staff forces a Department delay
- August 2021PCMA sues over a federal rule that made PBMs post rebate amounts. It later withdraws the suit after talks with the Biden administration.12
- April 15th, 2025President Trump signs Executive Order 14273. It tells the Labor Department to improve what employers can see of PBM pay.6
- January 2026The Labor Department proposes the rule.3
- March 2026PCMA asks the Department to withdraw the proposal after Congress passes its own PBM reforms.4
- June 2026PCMA sues Tennessee and Illinois over their state PBM laws.7
- October 29th, 2026The Department finalizes the rule. PCMA says it may exceed the Department's authority and that it will evaluate available pathways.11
- November 2nd, 2026The rule is published in the Federal Register.1
- January 4th, 2027The rule takes effect.1
- July 1st, 2027Plan years starting on or after this day fall under the rule.1
- January 1st, 2028Calendar-year plans first fall under the rule.5

Announced the final rule on October 29th, 2026. He said PBMs 'operated in the shadows, pocketing hidden fees.'2

Heads the agency that wrote the rule. He said employers who see what PBMs are paid can negotiate harder.2

Said the Department may have exceeded Congress's intent and its own authority. He said PCMA "will evaluate available pathways" against the rule. No lawsuit is reported.11
No case is reported, so no judge is named. A court reviewing the rule may postpone its effective date to prevent irreparable injury.8

Backs the rule. He said employers will be able to 'check the numbers, ask hard questions' and hold PBMs to their contracts.3
We add each shock to the quiet path twice and see where the answer ends each time. When both tries agree, the result is firm. When they differ, it is uncertain. The quiet path is the one with no new shock.
- changes it both times
- Both tries ended on a different level from the quiet path.
- no change either time
- Both tries ended where the quiet path ends.
In both quiet paths the rule is on schedule on March 31st, 2027. Plans whose year starts on July 1st, 2027 come under it first. Calendar-year plans follow on January 1st, 2028.5
- PCMA, the PBM lobby
- Says the Department may have exceeded Congress's intent and its own authority. It says it will evaluate available pathways against what it calls regulatory overreach.11
- STAT, a health news site
- Reports that PBMs and lobbyists warned they may take legal action when the rule was still a proposal.15
- K&L Gates, a law firm, on a 2020 drug pricing rule
- Reports that a Maryland federal court blocked a Medicare drug pricing rule on December 23rd, 2020. Drug makers had sued on December 4th. The rule was due to start on January 1st, 2021.16
- Experts quoted by Healthcare Dive
- Say transparency is not a silver bullet. The biggest PBMs control about 80% of US prescriptions between them.3
- This report
- A legal objection changes the answer only if it becomes a stay or a delay notice by March 31st, 2027. No page we gathered reports a lawsuit yet. The 2020 case shows a court can act in the same month as a complaint, so a late filing could still count. A weak market effect does not stop the rule from applying.
Each row is one shock added to the path with no new shock. The track shows which level the rule ends on.
Overstated
Healthcare Dive writes that the rule takes effect July 2027. The Federal Register gives January 4th, 2027 as the effective date. July 1st, 2027 is when it starts to apply to plan years.
Understated
No page we gathered reports a lawsuit as of November 15th, 2026. PCMA says only that it will evaluate available pathways. Every outcome that takes the rule off schedule needs a court order or a delay notice.
In 2021 PCMA sued over a federal rebate disclosure rule, then withdrew after talks with the Biden administration. The final version kept the data out of public view. Our outcome where a PBM settlement bends the rule follows the same path.
Crowell & Moring, a law firm, notes the Department already gives good-faith relief on the 2026 law's disclosures. It runs until the first plan year on or after July 1st, 2027. New grace-period guidance matters only if it reaches past that.
- Yes
- A lawsuit fails and the rule stays on time, or guidance and early audits settle the rule in.
- No
- Any other outcome, from an open court fight to a blocked rule.
- Yes
- A court blocks the rule before July, or PBM lawsuits on several fronts at once.
- No
- A lawsuit fails and the rule stays on time, guidance and early audits settle the rule in, or court and agency delays slow the rule.
- Yes
- Quiet deals soften the rule, a PBM settlement bends it, or a split inside the administration on enforcement.
- No
- The rule on schedule with no softening, or a court blocks it outright.
- Yes
- A rulemaking challenge meets a fraud case, or PBM lawsuits on several fronts at once.
- No
- A lawsuit fails and the rule stays on time, guidance and early audits settle the rule in, or quiet deals soften the rule.
- Yes
- The rule on schedule, or court and agency delays slow the rule but it still stands.
- No
- A court blocks the rule, lawsuits spread, a fraud case hits, or short staff forces a Department delay.
This page cites 18 sources. Every number on it is traced to one of them or to the run.
- The question
- Does the rule still apply to plan years from July 1st, 2027, with no court stay or delay notice by March 31st, 2027?
- The run
- Brief 72, run on November 7th, 2026. We ran each shock twice.
- How firm this is
- Every shock that took the rule off schedule, or put it in doubt, did so both times we tried it. Leaked pricing data left the rule on schedule both times. We found no earlier run of this question to compare with.
- The sources
- The Federal Register, the Labor Department, the Administrative Procedure Act, the federal court rules, PCMA's own statement, Axios, STAT, Healthcare Dive, Healthcare Brew, Fierce Healthcare, Healthcare Finance News, and the law firms Crowell & Moring and K&L Gates.
- Past cases
- The run found nine past federal rules that faced a delay or a court fight before they started. By their names, most were delayed or blocked. We checked three against stored pages. Courts blocked a Medicare drug pricing rule in December 2020 and an Affordable Care Act enrollment rule in August 2025. In March 2021 the Health Department postponed its own rule on reviewing old regulations, pending a court case. The run searched for delays and stays, so the list leans that way.
- What we left out
- Court dockets: we could not search them, so a lawsuit filed in the last few days could be missing. Which court would hear a case. Any financial or family interest of a Labor Department official in the outcome: no page we gathered reports one. A map: the subject has no place beyond Washington.
- A real result can be one we did not test.
- Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure
- US Department of Labor finalizes pharmacy benefit manager transparency rule
- Labor Department finalizes sweeping PBM disclosure rule
- Labor Department finalizes PBM transparency rule
- DOL Finalizes PBM Fee Disclosure Requirements
- Pharmacy Benefit Manager Fee Disclosure Final Rule
- PCMA sues to exempt PBMs from Illinois drug law
- 5 U.S. Code § 705 - Relief pending review
- 5 U.S. Code § 706 - Scope of review
- Rule 65. Injunctions and Restraining Orders
- PCMA: DOL Rule Threatens Smaller PBMs, Will Raise Costs for Patients, Employers
- PCMA pulls lawsuit over rebate disclosure rule after reaching deal with Biden admin
- Experts are split on what the Labor Department's new PBM transparency rule means
- New mandates force PBMs to disclose business dealings
- New federal rule will require prescription drug middlemen to share secret payments data
- Federal Courts Block Implementation of Most Favored Nation Drug Pricing Rule
- Federal court stays final rule on Affordable Care Act enrollment
- Securing Updated and Necessary Statutory Evaluations Timely; Administrative Delay of Effective Date